SMTL ID : 7vm7.1

Crystal structure of inactive uPA in complex with nafamostat

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.87 Å

Oligo State

monomer

Ligands

1 x 7RF: (6-carbamimidoylnaphthalen-2-yl) 4-carbamimidamidobenzoate(Non-covalent)

7RF.1: 18 residues within 4Å: Chain A: V.30, C.31, H.46, C.47, D.192, S.193, C.194, Q.195, G.196, D.197, A.198, V.216, S.217, W.218, G.219, G.221, C.222, G.229 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Q.195, A:Q.195, A:A.198, A:V.216 Hydrogen bonds: A:V.30, A:C.47, A:S.193, A:S.193, A:G.196, A:D.197, A:A.198, A:G.221 Water bridges: A:D.192 Salt bridges: A:H.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhou, Y. et al., Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat. Biophys.J. (2022)

Release Date

2022-11-23

Peptides

Urokinase-type plasminogen activator chain B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
U

Urokinase-type plasminogen activator chain B